An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals
about
An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals
description
im September 2019 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 05 September 2019
@en
wetenschappelijk artikel
@nl
name
An open-label phase 1 clinical ...... ab in HIV-infected individuals
@en
An open-label phase 1 clinical ...... ab in HIV-infected individuals
@nl
type
label
An open-label phase 1 clinical ...... ab in HIV-infected individuals
@en
An open-label phase 1 clinical ...... ab in HIV-infected individuals
@nl
prefLabel
An open-label phase 1 clinical ...... ab in HIV-infected individuals
@en
An open-label phase 1 clinical ...... ab in HIV-infected individuals
@nl
P2093
P50
P1476
An open-label phase 1 clinical ...... ab in HIV-infected individuals
@en
P2093
Catherine Seamon
Erin D Huiting
Jesse Shawn Justement
Katherine E Clarridge
P304
P356
10.1126/SCITRANSLMED.AAX3447
P50
P577
2019-09-05T00:00:00Z